Q4 2024 Halozyme Therapeutics Inc Earnings Call
Helen Torley; President, Chief Executive Officer, Director; Halozyme Therapeutics Inc Nicole Labrosse; Chief Financial Officer, Senior Vice President; Halozyme Therapeutics Inc Good afternoon. My name ...
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 18, 2025 Halozyme Therapeutics, Inc. beats earnings expectations. Reported EPS is ...
Injectable Drug Delivery Devices Market Size Expected To Reach USD 1,217 Bn By 2034
The global injectable drug delivery devices market size is calculated at USD 565 billion in 2025 and is expected to reach around USD 1,217 billion by ...
Medscape2h
Intravenous to Subcutaneous Infliximab Switch Shows Promise in IBD Management
Switching from IV to subcutaneous infliximab maintenance therapy is associated with high treatment persistence and a stable ...
Healio21h
FDA sets date for decision on twice-yearly shots to prevent HIV
The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV ...
Business Wire3h
Medincell Announces Successful c.€43 Million Global Offering
Medincell (Paris:MEDCL): This press release is not being made in and copies of it may not be distributed or sent, directly or indirectly, into the United States, Australia, South Africa, Canada or ...
Liver Cancer Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
Promising Liver Cancer Therapies such as Atezolizumab, Bevacizumab, Tiragolumab, OH2 injection, MTL-CEBPA, Sorafenib 200mg, ...
Future Market Insights7h
Global Human Growth Hormone Treatment and Drugs Market Poised for Steady Growth to Reach USD 5.26 Billion by 2033 at a CAGR of 3.7%
The global Human Growth Hormone Treatment and Drugs Market is expected to reach a value of around USD 5.26 billion by 2033, ...